Cargando…
Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor
Zika virus (ZIKV) has caused significant disease, with widespread cases of neurological pathology and congenital neurologic defects. Rapid vaccine development has led to a number of candidates capable of eliciting potent ZIKV-neutralizing antibodies (reviewed in refs. (1–3)). Despite advances in vac...
Ejemplares similares
-
Impact of prior Dengue immunity on Zika vaccine protection in rhesus macaques and mice
por: Larocca, Rafael A., et al.
Publicado: (2021) -
Human T cell responses to Dengue and Zika virus infection compared to Dengue/Zika coinfection
por: Badolato‐Corrêa, Jessica, et al.
Publicado: (2017) -
Landscape of Monoclonal Antibodies Targeting Zika and Dengue: Therapeutic Solutions and Critical Insights for Vaccine Development
por: Dussupt, Vincent, et al.
Publicado: (2021) -
Dengue virus antibodies enhance Zika virus infection
por: Paul, Lauren M, et al.
Publicado: (2016) -
Chikungunya, Dengue, and Zika in Immunocompromised Hosts
por: Darrigo, Luiz Guilherme, et al.
Publicado: (2018)